China Meheco Group Co., Ltd. (SHA:600056)

Market Cap	16.13B +2.7%
Revenue (ttm)	33.23B -7.3%
Net Income	513.36M -44.8%
EPS	0.34 -44.8%
Shares Out	1.50B
PE Ratio	31.41
Forward PE	n/a
Dividend	0.11 (0.98%)
Ex-Dividend Date	Sep 26, 2025

Volume	19,603,610
Average Volume	22,608,870
Open	10.82
Previous Close	10.83
Day's Range	10.78 - 11.04
52-Week Range	9.54 - 12.48
Beta	0.23
RSI	50.11
Earnings Date	Apr 25, 2026

About China Meheco Group

China Meheco Group Co., Ltd. engages in the manufacture, marketing, and trade of pharmaceuticals and medical devices in China and internationally. The company is involved in the planting and sale of Chinese medicinal materials, as well as the provision of related technical and warehousing services. Its drug products cover therapeutic fields, such as anti-infection, cardiovascular, hormones and endocrine regulation, respiratory and digestive systems, nutritional supplements, antipyretic analgesics, and other therapeutic areas as well as Chinese ...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1983
• Employees: 8,368
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600056

Financial Performance

In 2024, China Meheco Group's revenue was 34.15 billion, a decrease of -12.04% compared to the previous year's 38.82 billion. Earnings were 535.47 million, a decrease of -48.91%.